Sakuranetin treatment from baccharis retusa reduces acid mucus in a murine model of asthma

Fernanda Paula Roncon Santana (Diadema, Brazil), Fernanda Paula Roncon Santana, Thaís Lourenço Ramos, Anna Carolina Morais Tavares, Nathália Montouro Pinheiros, Camila Pivari Pedroso Sadoka, Simone Dos Santos Grecco, Mariangela Macchione, Kelly Yoshizaki, Iolanda de Fátima Lopes Calvo Tibério, Milton de Arruda Martins, João Henrique Ghilardi Lago, Alessandra Choqueta Toledo, Carla Máximo Prado

Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Session: Preclinical pharmacology: drug targets and mechanisms of action
Session type: Thematic Poster
Number: 4089
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fernanda Paula Roncon Santana (Diadema, Brazil), Fernanda Paula Roncon Santana, Thaís Lourenço Ramos, Anna Carolina Morais Tavares, Nathália Montouro Pinheiros, Camila Pivari Pedroso Sadoka, Simone Dos Santos Grecco, Mariangela Macchione, Kelly Yoshizaki, Iolanda de Fátima Lopes Calvo Tibério, Milton de Arruda Martins, João Henrique Ghilardi Lago, Alessandra Choqueta Toledo, Carla Máximo Prado. Sakuranetin treatment from baccharis retusa reduces acid mucus in a murine model of asthma. Eur Respir J 2016; 48: Suppl. 60, 4089

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Potential effect of the extract of zataria multiflora and its consituent carvacrol on lung inflammation of sensitized guinea pigs
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013

Effects of rosemary and platanus extracts on asthmatic subjects resistant to traditional treatments
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013

Montelukast improves air trapping, not airway remodeling, in moderate-to-severe patients with asthma: A pilot tudy
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


Azithromycin exhibits interferon-inducing properties in an experimental mouse model of asthma exacerbation
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015

Achievement of asthma control in patients with cold airway hyperresponsiveness at different variants of basic therapy
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014

Resveratrol upregalates PTEN and inhibits MUC5AC expression in ovalbumin (OVA)-induced asthma model mice
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

In-vitro bronchodilator activity clitoria ternatea and A. precatorius
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

Study of antioxidant use in patients with asthma exacerbations
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013

Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015


Evaluation of bronchodilator activity of A. precatorius leaves
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

Polyphenolic compounds and experimentally induced allergic asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013

Rapamycin protects OVA induced asthma in mice through regulating autophagy
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015

Fatty acid blood spectrum in patients with asthma
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Gender differences in patients with aspirin-induced asthma (AIA)
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


The effect of oligomeric proanthocyanidin on airway microenvironment in asthma
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016


Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015